Abbott Vascular Inc - Product Pipeline Analysis, 2017 Update

Date: May 18, 2017
Pages: 53
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: ABB9003FE97EN
Leaflet:

Download PDF Leaflet

Abbott Vascular Inc - Product Pipeline Analysis, 2017 Update
Summary

Abbott Vascular Inc (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. Its coronary intervention products include bleedback control valve, coronary dilatation catheters, coronary drug eluting stents, coronary guide wires, and others. Abbott Vascular’s peripheral intervention products comprise peripheral guide wires, dilatation catheters, guiding catheters, and stent grafts. The company provides minimally invasive treatment for mitral regurgitation and other structural defects of the heart. It also offers education and training services for healthcare professionals. Abbott Vascular is headquartered in Santa Clara, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Abbott Vascular Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Abbott Vascular Inc Company Overview
Abbott Vascular Inc Company Snapshot
Abbott Vascular Inc Pipeline Products and Ongoing Clinical Trials Overview
Abbott Vascular Inc – Pipeline Analysis Overview
Abbott Vascular Inc - Key Facts
Abbott Vascular Inc - Major Products and Services
Abbott Vascular Inc Pipeline Products by Development Stage
Abbott Vascular Inc Ongoing Clinical Trials by Trial Status
Abbott Vascular Inc Pipeline Products Overview
Absorb GT1 Bioresorbable Vascular Scaffold
Absorb GT1 Bioresorbable Vascular Scaffold Product Overview
Absorb GT1 Bioresorbable Vascular Scaffold Clinical Trial
Chemical RDN System
Chemical RDN System Product Overview
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5)
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) Product Overview
ESPRIT Bioresorbable Vascular Scaffold
ESPRIT Bioresorbable Vascular Scaffold Product Overview
Next Generation SUPERA Delivery System
Next Generation SUPERA Delivery System Product Overview
Second Generation Bioresorbable Vascular Scaffold
Second Generation Bioresorbable Vascular Scaffold Product Overview
Tendyne Bioprosthetic Mitral Valve Implantation System
Tendyne Bioprosthetic Mitral Valve Implantation System Product Overview
Tendyne Bioprosthetic Mitral Valve Implantation System Clinical Trial
Xience SBA Everolimus Eluting Coronary Stent System
Xience SBA Everolimus Eluting Coronary Stent System Product Overview
XIENCE Thinman DES
XIENCE Thinman DES Product Overview
ZoMaxx Drug Eluting Coronary Stent System
ZoMaxx Drug Eluting Coronary Stent System Product Overview
Abbott Vascular Inc - Key Competitors
Abbott Vascular Inc - Key Employees
Abbott Vascular Inc - Locations And Subsidiaries
Head Office
Recent Developments
Abbott Vascular Inc, Recent Developments
May 12, 2017: Abbott Initiates Voluntarily Recall of NC Tenku RX PTCA Balloon Catheter
May 12, 2017: Abbott Initiates Voluntarily Recall of NC Traveler Coronary Dilatation Catheter
May 12, 2017: Abbott Initiates Voluntarily Recall of Specific Lots of NC Trek RX Coronary Dilatation Catheter
May 02, 2017: TGA Hazard Alert On Absorb Bioresorbable Vascular Scaffold System
Mar 27, 2017: Abbott Vascular Provides Update On Absorb Bioresorbable Vascular Scaffold
Mar 18, 2017: Absorb GT1 Bioresorbable Vascular Scaffold by Abbott Vascular: Letter to Health Care Providers - FDA Investigating Increased Rate of Major Adverse Cardiac Events
Mar 18, 2017: Late-Breaking Data on Abbott's MitraClip System Show Continued Benefit for People with Mitral Regurgitation, Most Common Heart Valve Disease
Feb 21, 2017: Ascension Michigan Leads State in Pioneering Dissolving Heart Stent
Feb 17, 2017: Absorbable Stents Offer Alternative for Wake Forest Baptist Cardiology Patients
Nov 07, 2016: Abbott's Absorb Bioresorbable Stent Approved as the First Fully Dissolving Heart Stent in Japan
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Abbott Vascular Inc Pipeline Products and Ongoing Clinical Trials Overview
Abbott Vascular Inc Pipeline Products by Equipment Type
Abbott Vascular Inc Pipeline Products by Indication
Abbott Vascular Inc Ongoing Clinical Trials by Trial Status
Abbott Vascular Inc, Key Facts
Abbott Vascular Inc, Major Products and Services
Abbott Vascular Inc Number of Pipeline Products by Development Stage
Abbott Vascular Inc Pipeline Products Summary by Development Stage
Abbott Vascular Inc Ongoing Clinical Trials by Trial Status
Abbott Vascular Inc Ongoing Clinical Trials Summary
Absorb GT1 Bioresorbable Vascular Scaffold - Product Status
Absorb GT1 Bioresorbable Vascular Scaffold - Product Description
Absorb GT1 Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Bioresorbable Vascular Scaffold, in the Treatment of Subjects with de Novo Native Coronary Artery Lesions in Chinese Population
Absorb GT1 Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold In the Treatment of Subjects with De Novo Native Coronary Artery Lesions
Absorb GT1 Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de Novo Native Coronary Artery Lesions
Absorb GT1 Bioresorbable Vascular Scaffold - A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System (BVS EECSS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions
Absorb GT1 Bioresorbable Vascular Scaffold - A Continuation in the Clinical Evaluation of the Abbott Vascular Everolimus-Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de Novo Native Coronary Artery Lesions: ABSORB EXTEND Clinical Investigation
Absorb GT1 Bioresorbable Vascular Scaffold - A Multicenter Prospective Natural History Study Using Multimodality Imaging in Patients with Acute Coronary Syndromes - PROSPECT II (Natural History Study), Combined with a Randomized, Controlled, Intervention Study - PROSPECT ABSORB (Randomized Trial)
Absorb GT1 Bioresorbable Vascular Scaffold - A Prospective Evaluation of a Standardized Strategy for the Use of Bioresorbable Vascular Scaffold in ST-segment Elevation Myocardial Infarction: The BVS STEMI STRATEGY-IT Registry
Absorb GT1 Bioresorbable Vascular Scaffold - A Prospective, Randomized Trial of Synergy Bioresorbable Polymer Coated Stents Versus Absorb Bioresorbable Backbone Stents in Patients Undergoing Coronary Stenting (ISAR-RESORB)
Absorb GT1 Bioresorbable Vascular Scaffold - A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold versus Everolimus-eluting Metallic Stent in Long Coronary Lesions
Absorb GT1 Bioresorbable Vascular Scaffold - A Randomized Trial of the Treatment of Non- Culprit Lesion After STEMI: Bioresorbable Vascular Scaffold Versus Optimal Medical Therapy (NCL Study)
Absorb GT1 Bioresorbable Vascular Scaffold - ABSORB Bioresorbable Scaffold versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis
Absorb GT1 Bioresorbable Vascular Scaffold - ABSORB III RCT Pharmacokinetics (PK) Sub-study
Absorb GT1 Bioresorbable Vascular Scaffold - ABSORB Post-approval Clinical Study
Absorb GT1 Bioresorbable Vascular Scaffold - Amsterdam Investigator-initiated Absorb Strategy All-comers Trial (AIDA Trial) - A Clinical Evaluation Comparing the Efficacy and Performance of ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold Strategy Versus the XIENCE Family (XIENCE PRIME or XIENCE Xpedition) Everolimus Eluting Coronary Stent Strategy in the Treatment of Coronary Lesions in Consecutive All-comers
Absorb GT1 Bioresorbable Vascular Scaffold - Bifurcation ABSORB OCT Trial
Absorb GT1 Bioresorbable Vascular Scaffold - Bioresorbable Vascular Stents for Treatment of Coronary Bifurcation Lesions Assessed by Optical Coherence Tomography - The BIFSORB Study
Absorb GT1 Bioresorbable Vascular Scaffold - Clinical Study on Absorb Polylactic, Reabsorbable Coronary Scaffold (RAI)
Absorb GT1 Bioresorbable Vascular Scaffold - Comparison of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold System with a Drug- Eluting Metal Stent (XienceTM) in Acute ST-Elevation Myocardial Infarction
Absorb GT1 Bioresorbable Vascular Scaffold - Complex Bifurcation Lesions - A Randomized Comparison Between the AXXESS Device in Combination with Absorb BVS, and Modified T Stenting with Absorb BVS: An OCT Study
Absorb GT1 Bioresorbable Vascular Scaffold - Comprehensive Imaging and Interventional Therapy Studies for Arteriogenic Erectile Dysfunction and Lower Urinary Tract Symptoms - A Multi-modality, Multi-specialty Collaborative Study (PERFECT Program)
Absorb GT1 Bioresorbable Vascular Scaffold - Dissection Re-entry Evaluation with Absorb Bioresorbable Vascular Scaffolds in Chronic Total Occlusion - The Discrete CTO Study
Absorb GT1 Bioresorbable Vascular Scaffold - Evaluation of Microcirculatory Protection in Percutaneous Revascularisation with Bioresorbable Vascular Scaffolds Versus Metallic Drug-eluting Stents: A Device- and Implant Technique-based Comparison
Absorb GT1 Bioresorbable Vascular Scaffold - Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease
Absorb GT1 Bioresorbable Vascular Scaffold - Everolimus-eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy in Heart Transplant Recipients: A Prospective Multicenter Pilot Study
Absorb GT1 Bioresorbable Vascular Scaffold - German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-Eluting Bioresorbable Vascular Scaffold System in Patients with Coronary Artery Stenosis
Absorb GT1 Bioresorbable Vascular Scaffold - Impact of Vascular Reparative Therapy on Vasomotor Function and Myocardial Perfusion: A Randomized H215O PET/CT Study
Absorb GT1 Bioresorbable Vascular Scaffold - Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct (BVS in STEMI)
Absorb GT1 Bioresorbable Vascular Scaffold - Prospective Study of Bioresorbable Vascular Scaffold Treatment with Scoring Balloon Pre-dilatation in Patients with In-stent Restenosis
Absorb GT1 Bioresorbable Vascular Scaffold - Real World Advanced Experience of Bioresorbable Scaffold by Smart Angioplasty Research Team (SMART REWARD)
Absorb GT1 Bioresorbable Vascular Scaffold - Safety and Feasibility of Bioabsorbable Everolimus-Eluting Stents for Patients with Internal Pudendal Artery-related Arteriogenic Erectile Dysfunction (PERFECT-ABSORB)
Absorb GT1 Bioresorbable Vascular Scaffold - Strut Coverage with SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction: An Intracoronary Optical Coherence Tomography Randomized Study
Chemical RDN System - Product Status
Chemical RDN System - Product Description
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Status
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Description
ESPRIT Bioresorbable Vascular Scaffold - Product Status
ESPRIT Bioresorbable Vascular Scaffold - Product Description
Next Generation SUPERA Delivery System - Product Status
Next Generation SUPERA Delivery System - Product Description
Second Generation Bioresorbable Vascular Scaffold - Product Status
Second Generation Bioresorbable Vascular Scaffold - Product Description
Tendyne Bioprosthetic Mitral Valve Implantation System - Product Status
Tendyne Bioprosthetic Mitral Valve Implantation System - Product Description
Tendyne Bioprosthetic Mitral Valve Implantation System - Early Feasibility Study of the Tendyne Mitral Valve System
Tendyne Bioprosthetic Mitral Valve Implantation System - Safety and Efficacy of Tendyne Bioprosthetic Mitral Valve System in Subjects with Symptomatic Mitral Regurgitation of Degenerative or Functional Etiology
Tendyne Bioprosthetic Mitral Valve Implantation System - Safety and Performance of the Tendyne Transcatheter Mitral Valve Implantation system (TMVI) in Inoperable Subjects with Mitral Regurgitation (MR)
Xience SBA Everolimus Eluting Coronary Stent System - Product Status
Xience SBA Everolimus Eluting Coronary Stent System - Product Description
XIENCE Thinman DES - Product Status
XIENCE Thinman DES - Product Description
ZoMaxx Drug Eluting Coronary Stent System - Product Status
ZoMaxx Drug Eluting Coronary Stent System - Product Description
Abbott Vascular Inc, Key Employees
Glossary

LIST OF FIGURES

Abbott Vascular Inc Pipeline Products by Equipment Type
Abbott Vascular Inc Pipeline Products by Development Stage
Abbott Vascular Inc Ongoing Clinical Trials by Trial Status

COMPANIES MENTIONED

Tryton Medical Inc
Cordis Corp
Bolton Medical Inc
Skip to top


Ask Your Question

Abbott Vascular Inc - Product Pipeline Analysis, 2017 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: